Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Touchstone Small Cap Fund Q3 2025 Contributors And Detractors
01:09pm, Wednesday, 26'th Nov 2025
Among the largest contributors to Fund performance were Armstrong World Industries, Ingevity Corporation, and Graham Holdings Co. Graham Holdings outperformed the benchmark on strong second quarter re
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 898 Shares of Haemonetics Corporation $HAE
04:09am, Monday, 24'th Nov 2025
Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in Haemonetics Corporation (NYSE: HAE) by 7.5% in the second quarter, according to its most recent disclosure with the Securi
Pharvaris: Biotech With De-Risked Phase 3 Readout Coming, Initiating With A Buy Rating
05:36am, Sunday, 23'rd Nov 2025
I initiate Pharvaris with a buy rating and $40 target price, driven by its differentiated oral bradykinin B2 antagonist franchise for HAE. PHVS's late-stage pipeline targets both on-demand and prophyl
Interpreting Haemonetics (HAE) International Revenue Trends
10:16am, Monday, 17'th Nov 2025
Review Haemonetics' (HAE) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Envestnet Asset Management Inc. Sells 15,910 Shares of Haemonetics Corporation $HAE
04:24am, Sunday, 16'th Nov 2025
Envestnet Asset Management Inc. cut its stake in Haemonetics Corporation (NYSE: HAE) by 28.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission.
Here's Why Haemonetics (HAE) is a Strong Growth Stock
10:46am, Friday, 14'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DAWNZERA™ (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)
07:00am, Friday, 14'th Nov 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the Committee for Medicinal Products for Human Use (CHMP
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 13'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Tuesday, 11'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million
11:50am, Saturday, 08'th Nov 2025
SG Capital sold 731,892 shares of Haemonetics. The investment firm currently holds 175,000 shares.
Why Haemonetics Stock Was on Fire Thursday
12:47pm, Friday, 07'th Nov 2025
It was something of an outlier in booking gains on a bearish day for stocks overall. This was the result of an investor-pleasing quarterly earnings report.
Haemonetics Is Still Undervalued, Even After The Rally
10:41am, Friday, 07'th Nov 2025
Haemonetics Corporation remains a Buy, supported by robust profit margins, strong cash flow, and leading TEG and plasma businesses driving organic growth. HAE reported improved gross and operating mar
The London Company Small Cap Q3 2025 Performance Update
07:25am, Friday, 07'th Nov 2025
The London Company Small Cap portfolio increased 1.9% gross (1.6% net) during the quarter vs. a 12.4% increase in the Russell 2000 Index. Armstrong World Industries' shares outperformed in the quarter
Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript
03:26am, Friday, 07'th Nov 2025
Haemonetics Corporation ( HAE ) Q2 2026 Earnings Call November 6, 2025 8:00 AM EST Company Participants Olga Guyette - Senior Director of Investor Relations Christopher Simon - CEO, President & Direct
Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 06'th Nov 2025
Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall
